Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
302.50    0.00 (0.00%)
Bid:
302.50
Ask:
303.00
Spread: 0.50 (0.165%)
Market Cap: £178.58m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Trading Statement

1 Oct 2014 07:00

RNS Number : 0649T
Treatt PLC
01 October 2014
 



1 October 2014

 

TREATT PLC

 

Trading Update for year ended 30 September 2014

 

Treatt Plc (the 'Group'), the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance and consumer goods industries today publishes a trading update for the year ended 30 September 2014.

 

Following the Q3 IMS published on 29 July 2014, the Board is pleased to confirm that the Group expects to report revenue and profit before tax in line with its expectations.

 

The underlying performance of the business for the year has been one of steady progress, building on the strategic foundations which were put in place in early 2013 although, as previously indicated, the relatively high raw material cost of certain key citrus ingredients will be reflected in higher than normal year-end inventory levels. The Board can also confirm that the FX strategy which is in place has resulted in movements in FX rates during the year not having a material impact on reported results.

 

Looking to the year ahead, the level of order books across the Group are satisfactory. Whilst raw material prices are expected to remain high, which in turn may impact upon margins, the Group expects to continue to see the benefits of its strategy of focusing on selling added-value ingredient solutions to leading FMCG and beverage businesses, whilst maintaining a tight control of costs.

 

Treatt Plc's results for the year ended 30 September 2014 will be announced on 9 December 2014.

 

 

 

For further information please contact:

Treatt Plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Finance Director

 

Brokers

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5169

 

Public relations

Davidson Ryan Dore

Lawrence Dore +44 (0)20 7520 9218

 

 

 

About the Group

Treatt is a leading global independent supplier of innovative ingredient solutions for the flavour, fragrance and consumer goods industries with manufacturing facilities in the UK, USA and Kenya.

 

Treatt employs over 300 staff in the UK, USA, Kenya, France and China. 

 

Treatt's product categories range from essential oils, particularly citrus oils, specialties for beverage and lower calorie products, fragrance ingredients, aroma and natural chemicals, organic and vegetable oils.

 

Naturally-derived cosmetic ingredients are supplied through Earthoil, the personal care and cosmetic ingredients division of Treatt, which specialises in the manufacture and supply of pure, organic, fair trade essential and cold pressed vegetable seed oils.

 

For further information about the Group, visit www.treatt.com and www.earthoil.com.

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFMGFLKGDGDZM
Date   Source Headline
28th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20255:34 pmRNSReplacement: Transaction in Own Shares
11th Apr 20252:25 pmRNSHolding(s) in Company
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20259:07 amRNSHolding(s) in Company
10th Apr 20257:01 amRNSShare Buyback Programme
10th Apr 20257:00 amRNSTrading Update
25th Mar 202511:30 amRNSVoting Rights and Capital
24th Mar 20257:00 amRNSDirectorate Change
19th Mar 20253:33 pmRNSDirector/PDMR Shareholding
6th Feb 20254:18 pmRNSHolding(s) in Company
4th Feb 202511:55 amRNSHolding(s) in Company
30th Jan 20254:17 pmRNSResult of AGM
30th Jan 20257:00 amRNSAGM Trading Update
20th Dec 202411:24 amRNSNotification of Transactions of Directors
17th Dec 20244:07 pmRNSAnnual Report and Notice of Annual General Meeting
17th Dec 20241:44 pmRNSNotification of Transactions of Directors
4th Dec 20241:47 pmRNS2024 Final Dividend
4th Dec 20247:00 amRNSFull Year Results
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
15th Nov 20247:00 amRNSBoard Change
16th Oct 202412:00 pmRNSChange in Director's Duties
10th Oct 20247:00 amRNSTrading Update
24th Sep 20242:06 pmRNSDirector/PDMR Shareholding
20th Aug 202411:06 amRNSNotification of Transactions of Directors
12th Jul 202410:49 amRNSDirector/PDMR Shareholding
4th Jun 202410:35 amRNSBlock Listing Six Monthly Return
4th Jun 202410:25 amRNSBlock Listing Six Monthly Return
3rd Jun 20247:00 amRNSDavid Shannon joins as CEO
14th May 20247:00 amRNSHalf Year Results
30th Apr 20244:02 pmRNSVoting Rights and Capital
10th Apr 20247:00 amRNSHalf Year Trading Update & Notice of Results
19th Mar 20243:40 pmRNSNotification of Transactions of Directors
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Feb 20249:35 amRNSHolding(s) in Company
31st Jan 20242:41 pmRNSNotification of Transaction of PDMR
25th Jan 20243:49 pmRNSResult of AGM
25th Jan 20247:00 amRNSAGM Trading Update
23rd Jan 20241:57 pmRNSTotal Voting Rights
21st Dec 20232:07 pmRNSNotification of Transaction of Director
15th Dec 20236:09 pmRNSNotification of Transactions - Replacement
15th Dec 20234:42 pmRNSNotification of Transactions of Directors
13th Dec 20237:00 amRNSInterim Chief Financial Officer Appointment
12th Dec 20234:24 pmRNSAnnual Report and Notice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.